Horizon Europe Work Programme: MSCA COFUND 2022

The MSCA COFUND 2022 (HORIZON-MSCA-2022-COFUND-01) is now open for new or existing doctoral or postdoctoral programmes with an impact on the enhancement of human resources in R&I at regional, national or international level.

Scope

• Proposed programmes can cover any research disciplines ("bottom-up"), but exceptionally can also focus on specific disciplines, notably when they are based on national or regional Research and Innovation Strategies for Smart Specialisation (RIS3 strategies). In this case, the range of covered disciplines should allow reasonable flexibility for the researchers to define their topic.

• Funding synergies with Cohesion policy funds and the Recovery and Resilience Facility (RRF) are strongly encouraged

• A Career Development Plan must be jointly established by the supervisor and each recruited researcher upon recruitment. In addition to research objectives, this Plan comprises the researcher's training and career needs, including training on transferable skills, teaching, planning for publications and participation in conferences and events aimed at opening science and research to citizens. The Plan must be established at the beginning of the recruitment and should be revised (and updated where needed) within 18 months.

Funding Information

• The check will normally be done for the coordinator if the requested grant amount is equal to or greater than EUR 500 000, except for:

  • public bodies (entities established as a public body under national law, including local, regional or national authorities) or international organisations; and

  • cases where the individual requested grant amount is not more than EUR 60 000 (lowvalue grant).

Eligible Activities

• Eligible activities are the ones described in the call conditions.

  • Projects must focus exclusively on civil applications and must not:

    • Aim at human cloning for reproductive purposes;

    • Intend to modify the genetic heritage of human beings which could make such changes heritable (except for research relating to cancer treatment of the gonads, which may be financed);

    • Intend to create human embryos solely for the purpose of research, or for the purpose of stem cell procurement, including by means of somatic cell nuclear transfer.

• The following activities are generally eligible for grants under Horizon Europe:

  • Research and innovation actions (RIA)

  • Innovation actions (IA)

  • Coordination and support actions (CSA)

  • Programme co-fund actions (CoFund)

  • Innovation and market deployment actions (IMDA)

  • Training and mobility actions (TMA)

  • Pre-commercial procurement actions (PCP)

  • Public procurement of innovative solutions actions (PPI)

Expected Outcome:

• Projects results are expected to contribute to the following outcomes:

  • For supported doctoral candidates or postdoctoral researchers

  • Deeper and more diverse set of research-related and transferable skills and competences;

  • Improved employability and career prospects both within academia and beyond;

  • New mind-sets and approaches to R&I work forged through interdisciplinary and inter-sectoral experience;

  • Enhanced networking and communication capacities with scientific peers, as well as with the general public that will increase and broaden the research and innovation impact.

For participating organisations

• Enhanced quality and sustainability of research training;

• Increased global attractiveness, visibility and reputation of the participating organisation(s);

• Stronger R&I capacity and output among participating organisations;

• Increased contribution of the participating organisations to the local, regional and/or national socio-economic ecosystems;

• Regular feedback of research results into teaching and education at participating organisations.